Mainstreaming Addiction Treatment Act of 2019
Latest action · May 31, 2019 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 2, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Mainstreaming Addiction Treatment Act of 2019
This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment).
Further, the bill directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.
Cosponsors 117
Members who signed on, in the order they did. Signatures ran from May 2, 2019 to Dec 16, 2020; 5 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NY | Antonio Delgado | Original | May 2, 2019 |
| D-NM | Ben Ray Luján | Original | May 2, 2019 |
| R-NY | Elise M. Stefanik | Original | May 2, 2019 |
| R-OH | Michael R. Turner | Original | May 2, 2019 |
| R-NC | Ted Budd | Original | May 2, 2019 |
| D-CA | Doris O. Matsui | May 7, 2019 | |
| D-NY | Gregory W. Meeks | May 7, 2019 | |
| D-CA | Harley Rouda | May 7, 2019 | |
| D-NJ | Jefferson Van Drew | May 7, 2019 | |
| D-TX | Lloyd Doggett | May 7, 2019 | |
| R-NC | Mark Meadows | May 7, 2019 | |
| D-WA | Pramila Jayapal | May 7, 2019 | |
| D-NY | Yvette D. Clarke | May 7, 2019 | |
| D-NJ | Albio Sires | May 9, 2019 | |
| D-NY | Anthony Brindisi | May 9, 2019 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 2, 2019 |
| Health Subcommittee | Referred May 3, 2019 | |
| House | Judiciary Committee | Referred May 2, 2019 |
| Crime and Federal Government Surveillance Subcommittee | Referred May 31, 2019 | |
| House | Ways and Means Committee | Referred May 2, 2019 |
Actions 4
Everything that happened, newest first.
- May 31, 2019Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
- May 3, 2019Referred to the Subcommittee on Health.
- May 2, 2019Introduced in House
- May 2, 2019Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In the Congressional Record 2
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H7998 | Antonio Delgado D-NY | Sep 26, 2019 |
| House | Debate and remarks H3508 | Antonio Delgado D-NY | May 9, 2019 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 165, no. 72, May 2, 2019, page H3441.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 116-106 | COMBATING AN EPIDEMIC: LEGISLATION TO HELP PATIENTS WITH SUBSTANCE USE DIS- SORDERS356 pages | Energy and Commerce Committee | Mar 3, 2020 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2074 | Mainstreaming Addiction Treatment Act of 2019 | Related bill | Jul 10, 2019 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V (such as buprenorphine) for maintenance or detoxificattion treatment, and for other purposes.
- Short Title(s) as Introduced
- Mainstreaming Addiction Treatment Act of 2019
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
Text 1
Each version as it was printed, newest first.
- May 2, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.